The Scientist

» pharmaceuticals and disease/medicine

Most Recent

image: Sea Star Comeback?

Sea Star Comeback?

By | May 9, 2016

Hordes of baby sea stars on the Pacific coast survived the summer and winter of 2015—promising news about populations that have been devastated by a wasting disease.

0 Comments

image: Breast Milk Primes Gut for Microbes

Breast Milk Primes Gut for Microbes

By | May 5, 2016

Maternal antibodies engender a receptive gut environment for beneficial bacteria in newborn mice.

2 Comments

image: Transparency Now

Transparency Now

By | May 1, 2016

Science is messy. So lay it out, warts and all.

1 Comment

image: Contributors

Contributors

By and | May 1, 2016

Meet some of the people featured in the May 2016 issue of The Scientist.

0 Comments

image: Antibodies Prevent HIV Infection in Monkeys

Antibodies Prevent HIV Infection in Monkeys

By | April 29, 2016

Infusing anti-HIV antibodies provides macaques with protection against infection for up to six months, according to a study.

0 Comments

image: “Hunger Hormone” No More?

“Hunger Hormone” No More?

By | April 20, 2016

Ghrelin promotes fat storage not feeding, according to a study.

3 Comments

image: Theranos in Criminal Probe

Theranos in Criminal Probe

By | April 19, 2016

Federal officials are investigating whether the diagnostics company misled investors.

2 Comments

image: Tracking Zika’s Evolution

Tracking Zika’s Evolution

By | April 15, 2016

Sequence analysis of 41 viral strains reveals more than a half-century of change. 

1 Comment

image: Psychedelic Neuroimaging

Psychedelic Neuroimaging

By | April 13, 2016

“Ego dissolution,” and other things that happen to the human brain on LSD

0 Comments

image: Cancer Tissue Repository Launched

Cancer Tissue Repository Launched

By | April 11, 2016

The Dana-Farber Cancer Institute will store tissue samples from patients with leukemia and lymphoma from which scientists can make patient-derived mouse models.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham